Wall Street analyst estimates for Radiopharm Theranostics Limited (RADX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Radiopharm Theranostics Limited, an Australian company established in Carlton in 2021, specializes in the research and development of cutting-edge radiopharmaceutical treatments. Their mission is to address critical gaps in healthcare by creating products for both diagnostic imaging and therapeutic intervention across a spectrum of challenging medical conditions.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 2.21 |
| EV / EBITDA | -1.01 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $8831 | $292359 | $299228 | $3.6M | $2.7M |
| Cost of Revenue | 0 | 0 | 0 | $3.6M | $4.8M |
| Gross Profit | $8831 | $292359 | $299228 | $39276 | -$2.1M |
| Research & Development | $4.1M | $13.8M | $17.6M | $27.5M | 0 |
| Selling, General & Admin | $10.8M | $13.0M | $15.2M | $16.5M | $15.9M |
| Operating Expenses | $19.9M | $34.8M | $36.9M | $38.2M | $64.7M |
| Operating Income | -$19.9M | -$34.5M | -$36.6M | -$38.2M | -$66.8M |
| EBITDA | -$18.0M | -$31.2M | -$44.1M | -$38.2M | -$66.8M |
| Interest Expense | $9.3M | $86091 | $642888 | $65300 | $109939 |
| Pre-tax Income | -$30.3M | -$34.6M | -$47.9M | -$38.2M | -$55.7M |
| Income Tax | $44397 | $38005 | $96364 | $103292 | -$53249 |
| Net Income | -$30.3M | -$34.6M | -$47.9M | -$38.3M | -$53.9M |
| EPS | $-29.76 | $-33.00 | $-36.00 | $-5.28 | $-4.56 |
| EPS (Diluted) | $-29.76 | $-33.00 | $-36.00 | $-5.28 | $-4.56 |
| Shares Outstanding (Diluted) | $1.0M | $1.0M | $1.3M | $6.9M | $11.8M |
Price
| Price | $1.67 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | AU |
Related companies: ADXN · BCLI · CDIO · CYCN · IBO · KTTA · MTNB
Explore sector: Healthcare · Biotechnology
More sections of RADX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks